These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16306794)
1. Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway. Zhang TT; Cui B; Dai DZ; Tang XY J Cardiovasc Pharmacol; 2005 Dec; 46(6):727-34. PubMed ID: 16306794 [TBL] [Abstract][Full Text] [Related]
2. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway. Zhang TT; Cui B; Dai DZ; Su W Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752 [TBL] [Abstract][Full Text] [Related]
3. Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats. Hung MW; Yeung HM; Lau CF; Poon AMS; Tipoe GL; Fung ML Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538666 [TBL] [Abstract][Full Text] [Related]
4. Effects of CPU 86017 (chlorobenzyltetrahydroberberine chloride) and its enantiomers on thyrotoxicosis-induced overactive endothelin-1 system and oxidative stress in rat testes. Tang X; Qi M; Dai D; Zhang C Urology; 2006 Aug; 68(2):455-61. PubMed ID: 16904483 [TBL] [Abstract][Full Text] [Related]
5. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels]. Tan JX; Huang XL; Wang B; Fang X; Huang DN Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571 [TBL] [Abstract][Full Text] [Related]
6. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice. Huh JW; Kim SY; Lee JH; Lee YS Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe. Yan LD; Kong LL; Yong Z; Dong HJ; Chi MG; Pan XF; Zhang C; Liang YJ; Gong ZH; Liu KL J Cardiovasc Pharmacol; 2010 Sep; 56(3):246-54. PubMed ID: 20531217 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. Na T; Dai DZ; Tang XY; Dai Y Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):39-49. PubMed ID: 17287947 [TBL] [Abstract][Full Text] [Related]
9. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651 [TBL] [Abstract][Full Text] [Related]
10. [Collagen expression of intra-acinar pulmonary arteries and right ventricle and intervention of Radix Astragali in rats with hypoxic pulmonary hypertension]. He J; Jing Z; Gu Q Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):654-6. PubMed ID: 11715451 [TBL] [Abstract][Full Text] [Related]
11. [Association between pulmonary vascular remodeling and expression of hypoxia-inducible factor-1α, endothelin-1 and inducible nitric oxide synthase in pulmonary vessels in neonatal rats with hypoxic pulmonary hypertension]. Wang JR; Zhou Y; Sang K; Li MX Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):138-44. PubMed ID: 23428131 [TBL] [Abstract][Full Text] [Related]
12. Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension. Blumberg FC; Lorenz C; Wolf K; Sandner P; Riegger GA; Pfeifer M Cardiovasc Res; 2002 Jul; 55(1):171-7. PubMed ID: 12062720 [TBL] [Abstract][Full Text] [Related]
13. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats. Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320 [TBL] [Abstract][Full Text] [Related]
14. Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influx. Gao J; Tang YQ; Dai DZ; Cheng YS; Zhang GL; Zhang C; Dai Y Acta Pharmacol Sin; 2012 May; 33(5):625-34. PubMed ID: 22555370 [TBL] [Abstract][Full Text] [Related]
15. Vardenafil ameliorates calcium mobilization in pulmonary artery smooth muscle cells from hypoxic pulmonary hypertensive mice. Chen WS; Li XQ; Cao W; Xiao X; Dong L; Zhang JZ Arch Med Res; 2012 May; 43(4):265-73. PubMed ID: 22704850 [TBL] [Abstract][Full Text] [Related]
16. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression. Chang H; Chang CY; Lee HJ; Chou CY; Chou TC Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619 [TBL] [Abstract][Full Text] [Related]
17. [Effect of hypoxia-inducible factor-1α, endothelin-1 and inducible nitric oxide synthase in the pathogenesis of hypoxia-induced pulmonary hypertension of the neonatal rats]. Sang K; Zhou Y; Li MX Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):919-24. PubMed ID: 23324150 [TBL] [Abstract][Full Text] [Related]
18. CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro. Yuan SH; Dai DZ; Guan L; Dai Y; Ji M Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1066-72. PubMed ID: 17042916 [TBL] [Abstract][Full Text] [Related]
19. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs. Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096 [TBL] [Abstract][Full Text] [Related]
20. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat. Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]